These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 30542082

  • 1. Cornell product in an electrocardiogram is related to reduced LV regional wall motion.
    Ishikawa J, Yamanaka Y, Watanabe S, Toba A, Harada K.
    Hypertens Res; 2019 Apr; 42(4):541-548. PubMed ID: 30542082
    [Abstract] [Full Text] [Related]

  • 2. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN, Devereux RB, Okin PM.
    J Electrocardiol; 2014 Apr; 47(5):630-5. PubMed ID: 25052475
    [Abstract] [Full Text] [Related]

  • 3. Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study.
    Okin PM, Devereux RB, Jern S, Julius S, Kjeldsen SE, Dahlöf B.
    Am J Hypertens; 2001 Aug; 14(8 Pt 1):775-82. PubMed ID: 11497193
    [Abstract] [Full Text] [Related]

  • 4. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahlöf B, LIFE Study Investigators.
    JAMA; 2004 Nov 17; 292(19):2343-9. PubMed ID: 15547161
    [Abstract] [Full Text] [Related]

  • 5. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
    Calderón A, Barrios V, Escobar C, Ferrer E, Barrios S, González-Pedel V, Montoro P, Navarro-Cid J.
    Clin Exp Hypertens; 2010 May 17; 32(3):145-53. PubMed ID: 20504121
    [Abstract] [Full Text] [Related]

  • 6. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM.
    J Electrocardiol; 2009 May 17; 42(6):584-8. PubMed ID: 19631946
    [Abstract] [Full Text] [Related]

  • 7. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
    Palmieri V, Okin PM, de Simone G, Bella JN, Wachtell K, Gerdts E, Boman K, Nieminen MS, Dahlöf B, Devereux RB.
    J Hypertens; 2007 May 17; 25(5):1079-85. PubMed ID: 17414673
    [Abstract] [Full Text] [Related]

  • 8. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Dahlöf B.
    Hypertension; 2000 Nov 17; 36(5):766-73. PubMed ID: 11082141
    [Abstract] [Full Text] [Related]

  • 9. Gender-Adjustment and Cutoff Values of Cornell Product in Hypertensive Japanese Patients.
    Ishikawa J, Yamanaka Y, Toba A, Watanabe S, Harada K.
    Int Heart J; 2017 Dec 12; 58(6):933-938. PubMed ID: 29162779
    [Abstract] [Full Text] [Related]

  • 10. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.
    Okin PM, Jern S, Devereux RB, Kjeldsen SE, Dahlöf B, LIFE Study Group.
    Hypertension; 2000 Jan 12; 35(1 Pt 1):13-8. PubMed ID: 10642268
    [Abstract] [Full Text] [Related]

  • 11. Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study.
    Larstorp AC, Okin PM, Devereux RB, Olsen MH, Ibsen H, Dahlöf B, Kjeldsen SE, Wachtell K.
    J Hum Hypertens; 2011 Mar 12; 25(3):178-85. PubMed ID: 20505749
    [Abstract] [Full Text] [Related]

  • 12. Left Ventricular Hypertrophy Findings on Electrocardiogram Predict Impaired Left Atrial Functions.
    Karagöz U, Kahya Eren N, Özdemir E, Emren SV, Gürsoy MO, Tokaç M.
    Turk Kardiyol Dern Ars; 2024 Jul 12; 52(5):322-329. PubMed ID: 38982819
    [Abstract] [Full Text] [Related]

  • 13. Gender differences in regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy.
    Okin PM, Gerdts E, Kjeldsen SE, Julius S, Edelman JM, Dahlöf B, Devereux RB, Losartan Intervention for Endpoint Reduction in Hypertension Study Investigators.
    Hypertension; 2008 Jul 12; 52(1):100-6. PubMed ID: 18504323
    [Abstract] [Full Text] [Related]

  • 14. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension.
    Okin PM, Wachtell K, Devereux RB, Harris KE, Jern S, Kjeldsen SE, Julius S, Lindholm LH, Nieminen MS, Edelman JM, Hille DA, Dahlöf B.
    JAMA; 2006 Sep 13; 296(10):1242-8. PubMed ID: 16968848
    [Abstract] [Full Text] [Related]

  • 15. ECG identification of left ventricular hypertrophy. Relationship of test performance to body habitus.
    Okin PM, Roman MJ, Devereux RB, Kligfield P.
    J Electrocardiol; 1996 Sep 13; 29 Suppl():256-61. PubMed ID: 9238409
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic performance of electrocardiographic criteria in echocardiographic diagnosis of different patterns of left ventricular hypertrophy.
    Oikonomou E, Theofilis P, Mpahara A, Lazaros G, Niarchou P, Vogiatzi G, Tsalamandris S, Fountoulakis P, Christoforatou E, Mystakidou V, Anastasiou M, Goliopoulou A, Tousoulis D.
    Ann Noninvasive Electrocardiol; 2020 May 13; 25(3):e12728. PubMed ID: 31724804
    [Abstract] [Full Text] [Related]

  • 17. Correlation between global longitudinal strain and QRS voltage on electrocardiogram in patients with left ventricular hypertrophy.
    Beladan CC, Popescu BA, Calin A, Rosca M, Matei F, Gurzun MM, Popara AV, Curea F, Ginghina C.
    Echocardiography; 2014 Mar 13; 31(3):325-34. PubMed ID: 24015855
    [Abstract] [Full Text] [Related]

  • 18. Influence of obesity on the diagnostic value of electrocardiographic criteria for detecting left ventricular hypertrophy.
    Abergel E, Tase M, Menard J, Chatellier G.
    Am J Cardiol; 1996 Apr 01; 77(9):739-44. PubMed ID: 8651126
    [Abstract] [Full Text] [Related]

  • 19. Electrocardiographic criteria which have the best prognostic significance in hypertensive patients with echocardiographic hypertrophy of left ventricle: 15-year prospective study.
    Djordjevic DB, Tasic IS, Kostic ST, Stamenkovic BN, Lovic MB, Djordjevic ND, Koracevic GP, Lovic DB.
    Clin Cardiol; 2020 Sep 01; 43(9):1017-1023. PubMed ID: 32492247
    [Abstract] [Full Text] [Related]

  • 20. A comparison of Cornell and Sokolow-Lyon electrocardiographic criteria for left ventricular hypertrophy in a military male population in Taiwan: the Cardiorespiratory fitness and HospItalization Events in armed Forces study.
    Su FY, Li YH, Lin YP, Lee CJ, Wang CH, Meng FC, Yu YS, Lin F, Wu HT, Lin GM.
    Cardiovasc Diagn Ther; 2017 Jun 01; 7(3):244-251. PubMed ID: 28567350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.